People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| OmniAb, Inc. | — | Biotechnology | Series B | $30.0M | $130.5M | 2025 |
Kurt W. Gustafson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kurt W. Gustafson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew W. Foehr | 1 | 4 |
| John W. Higgins | 1 | 1 |
| Jennifer W. Cochran | 1 | 1 |
| Charles W. Berkman | 1 | 1 |
| Philip J. Gotwals | 1 | 1 |
| Steve R. Love | 1 | 1 |
| Carolyn R. Bertozzi | 1 | 1 |
| Steve R. Crouse | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.